ATAI
NASDAQ · Pharmaceuticals
Ataibeckley Inc
$4.03
+0.02 (+0.50%)
Open$4.03
Previous Close$4.01
Day High$4.08
Day Low$3.95
52W High$6.75
52W Low$1.29
Volume—
Avg Volume4.44M
Market Cap1.47B
P/E Ratio—
EPS$-2.30
SectorPharmaceuticals
Analyst Ratings
Strong Buy
20 analysts
Price Target
+903.5% upside
Current
$4.03
$4.03
Target
$40.44
$40.44
$27.58
$40.44 avg
$50.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.66M | 2.70M | 436.73M |
| Net Income | -1,071,758,508 | -1,191,899,115 | 64.85M |
| Profit Margin | -16,142.0% | -46,040.8% | 14.9% |
| EBITDA | -1,079,556,593 | -1,216,403,523 | 102.81M |
| Free Cash Flow | — | — | 81.44M |
| Rev Growth | +161.0% | -75.3% | -6.2% |
| Debt/Equity | — | 0.20 | 0.24 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |